JPRN-UMIN000013170已完成1 期
Phase I trial of Docetaxel+Cisplatin+Cetuximab(TPE) for recurrent/metastatic head and neck squamous cell carcinoma - Phase I trial of Docetaxel+Cisplatin+Cetuximab(TPE) for recurrent/metastatic head and neck squamous cell carcinoma
Osaka University Graduate School of Medicine Otorhinolaryngolory-Head and Neck Surgery0 个研究点目标入组 12 人开始时间: 2014年3月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Past history of chemotherapy within 3 months 2) Past history of surgery or radiotherapy within 4 weeks 3) Double cancer within 2 years 4) Brain metastasis with active symptoms 5) Severe myelosuppressive or infectious status 6) Pulmonary fibrosis, acute lung injury, interstitial pneumonia 7) Other severe disease such as heart failure, kidney failure 8) Past history of allergy against docetaxel, cisplatin or cetuximab 9) Pregnant or nursing women 10) In the middle of other chemotherapy 11) Past history of cetuximab 12) Other significant disease that in the investigator's opinion would exclude the subject from the trial
研究者
相似试验
已完成
2 期
Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck CancerSquamous Cell Head and Neck CarcinomaRecurrent or Metastatic DiseaseNCT01289522Groupe Oncologie Radiotherapie Tete et Cou54
已完成
不适用
Phase II trial of docetaxel+cisplatin+capecitabine (DCX) therapy for unresectable or recurrent HER2-negative gastric cancerGastric cancerJPRN-UMIN000026722Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital35
招募中
2 期
Phase II trial of docetaxel (T), cisplatin (P) and fluorouracil (5-FU) in the treatment of metastatic penile cancerpatients with metastatic penile cancerJPRN-UMIN000002697Fudan University Shanghai Cancer Center40
已完成
1 期
Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following SurgeryRecurrent Lung Non-Small Cell CarcinomaStage IA Lung Non-Small Cell Carcinoma AJCC v7Stage IB Lung Non-Small Cell Carcinoma AJCC v7Stage IIA Lung Non-Small Cell Carcinoma AJCC v7Stage IIB Lung Non-Small Cell Carcinoma AJCC v7Stage IIIA Lung Non-Small Cell Cancer AJCC v7Stage IIIB Lung Non-Small Cell Cancer AJCC v7NCT00254384M.D. Anderson Cancer Center50
终止
2 期
Study of Induction Docetaxel, Cisplatin and 5-FluorouracilSquamous Cell CarcinomaOral CancerNCT00400205Emory University14